Is Merck & Co. Inc. Stock (MRK) Overbought or Oversold?
RSI analysis computed from MRK's daily closing prices · Data through July 2, 2026
As of July 2, 2026, MRK’s 14-day RSI is 68.4, inside the neutral 30–70 band — neither overbought nor oversold by the conventional thresholds.
RSI-14 Scale
MRK reads 68.4 on the 0–100 scale.
The Supporting Picture
vs 50-Day MA
+7.2%
MA: $118.31
vs 200-Day MA
+30.8%
MA: $96.95
From 52-Wk High
0.0%
High: $129.53
Volume vs 20-Day Avg
-4%
Avg: 6.2M shares
The 50-day average is currently above the 200-day average, which technicians read as a longer-term uptrend backdrop for the RSI reading above.
What's Behind the Reading
July 6, 2026Merck & Co. Inc. is currently in a neutral momentum posture, with an RSI-14 of 68.36, yet its price is at its 52-week high and trading 6.9% above its 50-day moving average. This reflects a period of sustained positive performance. The company reported first-quarter 2026 earnings on April 30, 2026, exceeding EPS estimates with a loss of $1.28 against an expected loss of $1.47. Revenue for the quarter also rose by 4.9% year-over-year to $16.29 billion, surpassing consensus estimates. While Merck recently terminated a Phase 2 clinical trial for an Alzheimer's candidate on July 1, 2026, this news was largely dismissed by institutional investors, as neuroscience is not a primary focus for the company. Positive analyst actions, including raised price targets from Bank of America and Scotiabank, have further contributed to the favorable market sentiment.
Recent Overbought / Oversold Episodes
How MRK behaved the last few times RSI left the neutral band — including its return over the 5 trading days after each episode ended.
| Episode | Period | Next 5 Days |
|---|---|---|
| overbought | June 29, 2026 – June 30, 2026 | — |
| overbought | February 19, 2026 – February 24, 2026 | -3.4% |
| overbought | February 3, 2026 – February 6, 2026 | -0.4% |
| overbought | January 6, 2026 – January 9, 2026 | -1.5% |
Past behavior does not predict future results — small sample sizes especially.
Frequently Asked Questions
Is Merck & Co. Inc. (MRK) overbought right now?
What is RSI (Relative Strength Index)?
Is an overbought stock a sell signal?
How often is this page updated?
Where does this data come from?
Methodology
The verdict on this page is mechanical: we compute the 14-day Relative Strength Index with Wilder’s smoothing from MRK’s daily closing prices, and apply the conventional thresholds — above 70 is overbought, below 30 is oversold. Moving averages, the 52-week range, and volume comparisons come from the same price history.
Indicators are recomputed after every market close. The AI commentary adds context from current news via grounded search, but never changes the computed verdict. Note: closes are as-traded; a stock split would distort readings for a few weeks until the window rolls past it.
Not Financial Advice
This page is for education and information only. Indicators are mechanical calculations, AI commentary can contain errors, and nothing here is a recommendation to buy or sell any security. Do your own research and consider consulting a qualified financial advisor. See our full disclaimer.
Keep Digging on MRK
Merck & Co. Inc. Overview
Price, chart, analysis & financials
MRK: Why Is It Moving?
Updated daily
MRK: Price Prediction
Updated daily
MRK: Undervalued or Overvalued?
Updated daily
Same question, Healthcare peers